11 Stocks With 3x-5x Returns This Year
The US stock market has endured a turbulent start to the year, with global crude oil prices spiking up and inflation surging to its highest level in two years, driven largely by the US-Israeli war on ...
Enliven Therapeutics Inc. (ELVN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | OrbiMed Advisors Samuel Isaly | 7,959,538 | $122,576,885 | 2.5% | |
| 2. | Commodore Capital Egen Atkinson And Michael Kramarz | 4,692,809 | $72,269,259 | 4.81% | |
| 3. | Vestal Point Capital Ryan Wilder | 3,830,000 | $58,982,000 | +231% | 2.01% |
| 4. | Polar Capital Brian Ashford-Russell And Tim Woolley | 3,513,680 | $54,110,672 | +14% | 0.21% |
| 5. | Point72 Asset Management Steve Cohen | 1,504,601 | $23,170,855 | +45% | 0.03% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $22.07 | 622 | $13,723.27 | 718,749 | 2023-02-23 | Filing | |
| $5.11 | 23,565 | $120,487.85 | 2,872,513 | 2023-02-22 | Filing | |
| $5.25 | 8,194 | $43,010.31 | 2,848,948 | 2023-02-21 | Filing | |
| $4.00 | 629,297 | $2,516,055.27 | 3,880,021 | 2023-01-03 | Filing | |
| $3.93 | 19,299 | $75,845.07 | 3,250,724 | 2022-12-09 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $35.10 | 40,000 | $1,404,024.00 | 25,000 | 2026-03-25 | Filing | |
| $27.76 | 5,000 | $138,800.00 | 25,000 | 2026-03-17 | Filing | |
| $30.19 | 10,129 | $305,826.92 | 25,000 | 2026-03-10 | Filing | |
| $30.02 | 29,871 | $896,811.06 | 25,000 | 2026-03-09 | Filing | |
| $29.58 | 10,000 | $295,839.00 | 51,000 | 2026-03-06 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 43,056 | $1,687,795 | 0.11% | |
| 2. | 7,000 | $274,400 | 0.19% | |
| 3. | 1,575 | $61,740 | 0.01% | |
| 4. | 1,333 | $52,254 | 0% | |
| 5. | 810 | $30,610 | 0% |
News See All
10 Best Performing Stocks of Q1 2026 to Watch for Q2
On April 3, Reuters reported that in the coming week, upcoming inflation data and initial company earnings could begin to show how the Middle East war is affecting the US economy and corporate America...
Enliven Therapeutics (ELVN) Soars to 5-Year High as Analysts 'Upbeat'
In a market note, Mizuho raised its price target for Enliven Therapeutics Inc. (NASDAQ:ELVN) to $45 from $41 previously, while maintaining an “outperform” rating.
10 Stocks Investors Are Buying Now: Chewy, Braze, Sarepta, and More
The company said that it has begun recruiting highly-skilled German talent to operationalize its upcoming satellite manufacturing facility in Berlin, as part of its plan to double the production capacity...
Enliven Therapeutics, Inc. (ELVN) Backed by Goldman Sachs After Strong Trial Data
Enliven Therapeutics, Inc. (NASDAQ:ELVN) is among the best NASDAQ stocks under $50 to buy. On Monday, analysts at Goldman Sachs started coverage on Enliven Therapeutics, Inc.
10 Best NASDAQ Stocks Under $50 to Buy
In this era where everyone is striving for the best, whether it be something in daily life or technology, the stock market is no exception.